Clinical Trials Browser

Phase 2 × Sarcoma × Bevacizumab × Clear all

NCT01327612 2021-02-21

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Phase 2 Completed

12 enrolled 21 charts

EndocrineGastrointestinalLymphoidSarcomaThoracic

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lymphoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

NCT01492673 2019-10-29

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Phase 2 Completed

9 enrolled 9 charts

Neuroblastoma, Sarcoma, Sarcoma, Ewing

NCT00643565 2019-10-22

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Phase 2 Completed

154 enrolled 19 charts

Sarcoma

NCT00356031 2017-05-19

Bevacizumab and Radiation Therapy for Sarcomas

Phase 2 Completed

20 enrolled 16 charts

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Benign Fibrous

NCT01222715 2017-05-05

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Phase 2 Completed

87 enrolled 11 charts

Rhabdomyosarcoma, Sarcoma

NCT00887809 2016-01-25

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Phase 2 Completed

47 enrolled 7 charts

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma

NCT00755261 2015-05-08

Phase II Study of Doxorubicin and Avastin® in Sarcoma.

Phase 2 Terminated

4 enrolled 4 charts

Sarcoma

NCT00052390 2013-06-24

Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma